Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Hereditary Cancer364.5M43.52%
Prenatal177.1M21.14%
Pharmacogenomics170.2M20.32%
Tumor Profiling125.8M15.02%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States (U.S.)769.5M91.87%
Rest of world (RoW)68.1M8.13%